IDEXX SDMA
Interpreting your SDMA results
IDEXX SDMA algorithm
An elevated SDMA* concentration is a reflection of impaired glomerular filtration rate (GFR). Both primary kidney disease
and secondary kidney insults, such as concurrent disease, can cause an elevation in SDMA concentration. Follow
this algorithm to investigate elevated SDMA concentrations and determine whether acute, active, or chronic injury is
occurring. Also use the algorithm to follow up an increased SDMA with further investigation, management, and monitoring with the IMM protocol.


Initial steps in investigating, managing, and monitoring impaired GFR as identified by an elevated SDMA
Investigate
Underlying cause, treatable condition, concurrent disease, chronic kidney disease (CKD)

Underlying cause
- Urinary tract infection (UTI)/pyelonephritis
- Toxicity (e.g., NSAIDs, ethylene glycol, lilies)
- Acute kidney Injury
- Systemic hypertension
- Chronic kidney disease (CKD)

Consider performing
- Urine culture and minimum inhibitory concentration (MIC) susceptibility
- Infectious disease testing
- Abdominal imaging
- Urine protein:creatine (UPC) ratio (proteinuria)
- Blood pressure

Concurrent condition to assess
- Hydration status
- Thyroid status (feline)
Manage
Treat underlying disease, manage assessed kidney injury, adjust care protocols

Treat appropriately
- Underlying disease (e.g., pyelonephritis, infectious disease)
- Dehydration
- Discontinue nephrotoxic medications (e.g., NSAIDs)
- Hypertension
- Proteinuria

Additional support
- Ample, clean water
- Kidney-supportive diet if warranted

Adjust anesthesia protocols
- Provide fluids (intravenous or subcutaneous)
- Oxygen support prior to, during, and after procedure
- Adjust pain management
Monitor
Manage and monitor outcomes

Monitor renal biomarkers
Trended testing of the following:
- SDMA, BUN, creatinine, and phosphorus
- Urinalysis
- Blood pressure
Outcome

GFR impairment, stable
SDMA remains increased, but stable
- GFR remains impaired but stable
- Consider CKD diagnosis, refer to IRIS staging and treatment guidelines
- Institute appropriate supportive care and monitoring

GFR impairment, progressive
SDMA continues to increase
- Ongoing active kidney injury
- Revisit investigate: repeat or additional diagnostics
- Institute ongoing supportive care

GFR recovery
SDMA returns to normal
- Recovery from mild injury
- Response to appropriate therapy
- Compensatory mechanisms
*Symmetric dimethylarginine.
For a complete list of references, visit idexx.co.uk/sdma.
The information contained herein is intended to provide general guidance only. As with any diagnosis or treatment, you should use clinical discretion with each patient based on a complete evaluation of the patient, including history, physical presentation, and complete laboratory data. With respect to any drug therapy or monitoring program, you should refer to product inserts for a complete description of dosages, indications, interactions, and cautions. Diagnosis and treatment decisions are the ultimate responsibility of the primary care veterinarian.